Brief: Calliditas Therapeutics Submits Supplemental New Drug Application To FDA
21/06/2023 11:20
June 21 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* CALLIDITAS THERAPEUTICS SUBMITS SUPPLEMENTAL NEW DRUG
APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR FULL
APPROVAL OF TARPEYO ®
Source text for Eikon: ID:nWkrbpb7TD
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations